{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2003"],"condition":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2020036"],"location":["Canada","United States","Spain"],"study_start_month":["12"],"keyword":["Cetuximab"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer","description":"The purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancer","dates":{"creation":"2003-12-15"},"accession":"2020036","cross_references":{"ClinicalTrials___gov":["NCT00207155"]}}